13FPulse
中
LP

LPCN LIPOCINE INC

2026Q2 · CUSIP 53630X203 · Sector: Healthcare & Biotech

Funds left

Funds are exiting, but the price is holding

Funds that own it
35
Institutions that reported holding it to the SEC
Net decrease in holders
11
Last quarter 46 → now 35
How unusual is that
Bottom 20%
Stronger than only 12% of US stocks
What the filings say, in one paragraph

35 funds held LPCN at the end of 2026Q2, down 11 from the quarter before. Buying has faded, though the price is holding up. On the business itself, revenue over the last 12 months was $2M, return on equity is -54.4%. LPCN has had 1 buying rushes in its history. It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2021Q2: holders=1 2021Q3: holders=1 2023Q2: holders=24 2023Q3: holders=21 2023Q4: holders=19 2024Q1: holders=18 2024Q2: holders=19 2024Q3: holders=18 2024Q4: holders=17 2025Q1: holders=19 2025Q2: holders=18 2025Q3: holders=22 2025Q4: holders=26 2026Q1: holders=46 2026Q2: holders=35 -23 -11.5 +0 +11.5 +23 02549 21Q221Q323Q223Q323Q424Q124Q224Q324Q425Q125Q225Q325Q426Q126Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 1 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q1 Top 20% — —

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
17
Change in large funds
0
Total value they hold
$7M
Funds buying for the first time
4
Funds that sold out entirely
15
Price change that quarter
—
Funds holding puts (bearish)
0
Funds holding calls (bullish)
0

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
—
EPS (TTM)
$-1.79
EPS YoY
—
Revenue (TTM)
$0.0B
Revenue YoY
—
Net margin
—
ROE
-54.4%
Debt ratio
8.7%
FCF (TTM)
—
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2022-06-30: EPS -0.61 2022-09-30: EPS -0.52 2022-12-31: EPS -0.98 2023-03-31: EPS -0.76 2023-06-30: EPS -0.68 2023-09-30: EPS -1.27 2023-12-31: EPS -0.43 2024-03-31: EPS 0.66 2024-06-30: EPS -0.56 2024-09-30: EPS -0.44 2025-03-31: EPS -0.35 2025-06-30: EPS -0.41 2025-09-30: EPS -0.59 2025-12-31: EPS -0.34 2026-03-31: EPS -0.54 2026-06-30: EPS -0.32 0M 4M 8M $M -1.40 -0.34 0.73 201720182019202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

Quarterly free cash flow
-5M-3M0K 20162017201820192020202120222023202420252026
Latest quarter $-2M (2023-12-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.